Network origin in Kristen Oberg first degree
Entity | Entity type | Industry | |
---|---|---|---|
Mycovia Pharmaceuticals, Inc.
Mycovia Pharmaceuticals, Inc. BiotechnologyHealth Technology Mycovia Pharmaceuticals, Inc. develops novel drugs in areas of unmet medical need, with an initial focus in women?s health. Its product candidate, VT-1161, engages in developed as a treatment for recurrent vulvovaginal candidiasis. The company was founded in 2018 and is headquartered in Durham, NC.
2
| Holding Company | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kristen Oberg via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Quintiles Capital Solutions
Quintiles Capital Solutions Investment ManagersFinance Quintiles Capital Solutions (Quintiles Capital) is a venture capital firm founded in 2000. The firm is headquartered in Durham, North Carolina. | Investment Managers | Chief Operating Officer | |
NovaQuest Capital Management LLC
NovaQuest Capital Management LLC Investment ManagersFinance NovaQuest Capital Management LLC (NovaQuest Capital Management) is a private equity firm founded in 2010 by John Layton Bradley and Jonathan Edward Tunnicliffe. The firm is headquartered in Raleigh, North Carolina. | Investment Managers | Chief Operating Officer | |
Sheffield Hallam University | College/University | Masters Business Admin | |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Undergraduate Degree | |
The University of Newcastle | College/University | Graduate Degree | |
The Fuqua School of Business | College/University | Masters Business Admin | |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Biotechnology | Corporate Officer/Principal | |
Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
BioStratum, Inc.
BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of South Carolina | College/University | Corporate Officer/Principal | |
Technische Universität Darmstadt | College/University | Graduate Degree |
Statistics
International
United States | 7 |
United Kingdom | 3 |
Germany | 3 |
Australia | 2 |
Sectoral
Consumer Services | 8 |
Finance | 3 |
Health Technology | 3 |
Operational
Corporate Officer/Principal | 3 |
Chief Operating Officer | 3 |
Masters Business Admin | 2 |
Graduate Degree | 2 |
Private Equity Investor | 1 |
Most connected contacts
Insiders | |
---|---|
Patrick Jordan | 7 |
Thorsten P. Degenhardt | 6 |
- Stock Market
- Insiders
- Kristen Oberg
- Company connections